Rising to the Challenge of the New NCEP ATP III Guidelines: Exceeding Current Therapeutic LimitationsByH. Bryan Brewer, JR, MDFebruary 1st 2002
State of the Art in Cholesterol Management: Targeting Multiple PathwaysByStephen D. Turley, PhDFebruary 1st 2002
Preclinical and Clinical Pharmacology of a New Class of Lipid Management AgentsByLawrence L. Rudel, PhDFebruary 1st 2002
An Investigative Look: Selective Cholesterol Absorption Inhibitors - Embarking on a New Standard of CareByEvan A. Stein, MD, PhDFebruary 1st 2002
